| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/02/2004 | US6699967 Used to treat, prevent, or delay a tissue proliferation-associated disorder |
| 03/02/2004 | US6699965 Used for as a drug screening target; protein from rat and human brains |
| 03/02/2004 | US6699843 Method for treatment of tumors using nucleic acid ligands to PDGF |
| 03/02/2004 | US6699713 Sample chamber modules are capable of being handheld |
| 03/02/2004 | US6699705 Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics |
| 03/02/2004 | US6699700 A mutant of the alcaligenes enzyme; production from an escherichia coli host cell; insusceptible to bilirubin when measuring creatinine due to its optimum weakly acidic ph range |
| 03/02/2004 | US6699698 Method and sample mount system for the in situ separation and enrichment of substances |
| 03/02/2004 | US6699695 For example, converting 2-hydroxy-4-methylthiobutyronitrile into the corresponding amide, which is a precursor to the feed supplement 2-hydroxy-4-methylthiobutyric acid |
| 03/02/2004 | US6699694 Method for producing α-1,6-branched α-1,4-glucans from sucrose |
| 03/02/2004 | US6699692 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
| 03/02/2004 | US6699691 Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast |
| 03/02/2004 | US6699690 Linked and controlling the expression of a heterologous enzyme, for example varicella zoster virus thymidine kinase or non-mammaliam cytosine deaminase |
| 03/02/2004 | US6699689 Mass production method of antimicrobial peptide and DNA construct and expression system thereof |
| 03/02/2004 | US6699687 Circularly permuted fluorescent protein indicators |
| 03/02/2004 | US6699686 Modified nuclear glucocorticoid receptor, fusion protein, and DNA fragments coding for said receptor and said fusion protein |
| 03/02/2004 | US6699682 Assay for inhibitors of fatty-acid amide hydrolase |
| 03/02/2004 | US6699677 Identifying a ligand-orphan receptor interaction by use of immobilized tethered ligand fusion proteins having a ligand domain, a stalk domain, and optionally an immobilization domain; drug screening, diagnosis |
| 03/02/2004 | US6699672 Heparanase specific molecular probes and their use research and medical applications |
| 03/02/2004 | US6699665 Multiple array system for integrating bioarrays |
| 03/02/2004 | US6699663 Molecular sequence of swine retrovirus |
| 03/02/2004 | US6699660 Isolated nucleic acid identical to one expressed in response to seizure or ischemia |
| 03/02/2004 | US6699658 Yeast cell surface display of proteins and uses thereof |
| 03/02/2004 | US6699657 In vitro system for replication of RNA-dependent RNA polymerase (RDRP) viruses |
| 03/02/2004 | US6699515 Process for the production of alcoholic beverages using maltseed |
| 03/02/2004 | US6699483 Cancer treatments |
| 03/02/2004 | US6699482 Leptospira rare outer membrane proteins |
| 03/02/2004 | US6699479 Recombinant newcastle disease virus as an embryo vaccine |
| 03/02/2004 | US6699476 Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules |
| 03/02/2004 | US6699475 Recombinant pox virus for immunization against tumor-associated antigens |
| 03/02/2004 | US6699473 Human anti-epidermal growth factor receptor single-chain antibodies |
| 03/02/2004 | US6699468 Defective expression of the gamma 34.5 gene and the ribonucleotide reductase gene |
| 03/02/2004 | US6699466 IL-16 antagonist peptides and DNA encoding the peptides |
| 03/02/2004 | CA2229405C Methods for enhancing the production of interferon in cell culture |
| 03/02/2004 | CA2149441C Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 03/02/2004 | CA2069960C Bispecific heteroantibodies with dual effector functions |
| 03/02/2004 | CA2003051C Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization |
| 02/29/2004 | WO2004016767A2 Evolving new molecular function |
| 02/29/2004 | CA2495881A1 Evolving new molecular function |
| 02/26/2004 | WO2004017069A1 Biochip analyzer and online anaylsis system |
| 02/26/2004 | WO2004017068A1 Method of detecting nucleic acid by using dna microarrays and nucleic acid detection apparatus |
| 02/26/2004 | WO2004017062A1 The method and device for accelerating molecular hybridization by ultrasonic wave |
| 02/26/2004 | WO2004017044A2 Chimeric protein |
| 02/26/2004 | WO2004017042A2 Methods and reagents for surface functionalization |
| 02/26/2004 | WO2004016814A1 Method of estimating drug metabolic activity by analyzing mutations in glucuronosyl transferase gene |
| 02/26/2004 | WO2004016812A1 Avian sex determination method |
| 02/26/2004 | WO2004016811A2 Methods and kit for genes shuffling using tagged primers |
| 02/26/2004 | WO2004016806A1 Using a polymerase with 3' to 5' exonuclease activity to perform gene sequence analysis |
| 02/26/2004 | WO2004016805A2 Immunostimulatory nucleic acids |
| 02/26/2004 | WO2004016803A2 Method of enhancing cd4+ t cell responses |
| 02/26/2004 | WO2004016795A1 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 02/26/2004 | WO2004016794A1 Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines |
| 02/26/2004 | WO2004016793A2 Method of plastid transformation in asteraceae, vector for use therein and plants thus obtained |
| 02/26/2004 | WO2004016792A1 Novel expression vector suitable for expression of recombinant protein at low temperature |
| 02/26/2004 | WO2004016791A1 Methods of mixing large numbers of heterologous genes |
| 02/26/2004 | WO2004016790A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 02/26/2004 | WO2004016789A1 Sugar chain library constructed via cargo receptor gene modification |
| 02/26/2004 | WO2004016788A1 Splicing-variant of the human p53 protein and use thereof in the production of pharmaceutical preparations for treating tumoural diseases |
| 02/26/2004 | WO2004016787A1 Modified tailed oligonucleotides |
| 02/26/2004 | WO2004016786A2 Dna expression construct for multiple gene expression |
| 02/26/2004 | WO2004016782A1 Method of assaying interaction between proteins |
| 02/26/2004 | WO2004016780A1 Adeno-associated virus vector inhibiting gene's function by rnai |
| 02/26/2004 | WO2004016779A1 A method for transdifferentiating mesenchymal stem cells into neuronal cells |
| 02/26/2004 | WO2004016778A1 Improved methods of in vitro protein synthesis |
| 02/26/2004 | WO2004016777A2 Genetically modified non-human mammal cells, procedure for their production and use in toxicity tests |
| 02/26/2004 | WO2004016776A1 Use of cdx2 +/- heterozygous animals for the screening of carcinogenic or anti-cancerous factors |
| 02/26/2004 | WO2004016775A2 Plants having modified growth and a method for making the same |
| 02/26/2004 | WO2004016773A1 Transgenic cloned cow producing human prourokinase and method for producing the same |
| 02/26/2004 | WO2004016769A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 02/26/2004 | WO2004016766A2 Real time measurement of cellular responses |
| 02/26/2004 | WO2004016764A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 02/26/2004 | WO2004016761A2 Gene therapy for critical limb ischemia with wild type or mutant enos |
| 02/26/2004 | WO2004016760A2 Novel variant hyprocrea jecorina cbh1 cellulases |
| 02/26/2004 | WO2004016759A2 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 02/26/2004 | WO2004016754A2 ANTISENSE MODULATION OF Nav1.3 EXPRESSION |
| 02/26/2004 | WO2004016749A2 Antisense modulation of acyl-coa synthetase 1 expression |
| 02/26/2004 | WO2004016748A2 Biotinylation of proteins |
| 02/26/2004 | WO2004016745A2 Backterial effector proteins which inhibit programmed cell death |
| 02/26/2004 | WO2004016742A2 α(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND α(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM |
| 02/26/2004 | WO2004016740A2 Humanized rabbit antibodies |
| 02/26/2004 | WO2004016735A2 Modulation of biological signal transduction by rna interference |
| 02/26/2004 | WO2004016732A2 Astrocyte modulated genes and uses thereof |
| 02/26/2004 | WO2004016730A2 Bacteria that can overproduce and secrete proteins |
| 02/26/2004 | WO2004016726A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 02/26/2004 | WO2004016652A2 Mammaglobin promoter |
| 02/26/2004 | WO2004016651A2 Spider silk polypeptide |
| 02/26/2004 | WO2004016650A1 Antimicrobial peptides, polypeptides comprising same, genes coding for said peptides, vectors, transformed organisms and compositions containing same |
| 02/26/2004 | WO2004016649A2 Method for the production of an artificial polypeptide and artificial proteins produced by said method |
| 02/26/2004 | WO2004016639A1 Bmp-2 estrogen responsive element and methods of using the same |
| 02/26/2004 | WO2004016638A1 Aptamer-mediated regulation of gene expression |
| 02/26/2004 | WO2004016637A1 Gene families associated with liver cancer |
| 02/26/2004 | WO2004016636A1 Gene families associated with stomach cancer |
| 02/26/2004 | WO2004016283A2 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 02/26/2004 | WO2004016280A1 Recombinant bcg vaccine |
| 02/26/2004 | WO2004016274A2 Novel peptide-conjugated oligomeric compounds |
| 02/26/2004 | WO2004016227A2 Screening methods for cognitive enhancers |
| 02/26/2004 | WO2004016224A2 Antisense modulation of vegf co-regulated chemokine-1 expression |
| 02/26/2004 | WO2004016223A2 Assaying compounds or agents for microsomal prostaglandin e synthase or hematopoietic prostaglandin d synthase activity |
| 02/26/2004 | WO2004016220A2 Apicomplexan pathways, inhibitiors, and drug delivery |
| 02/26/2004 | WO2004016215A2 Use of antisense oligonucleotides to inhibit the expression of akt-1 |
| 02/26/2004 | WO2004016212A2 Methods and compositions for targeting secretory lysosomes |